Analystreport

CVS Health Corp (NYSE: CVS) had its price target raised by analysts at UBS Group AG to $67.00. They now have a "sell" rating on the stock.

CVS Health Corporation  (CVS) 
Last cvs health corporation earnings: 2/12 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.cvshealth.com